ROCHE Finance Ltd. is 10% Owner at Jasper Therapeutics, Inc. (JSPR). They have made 1 open-market trade across 1 company since 2023, most recently 2023-01-25.
CIK 0001053942
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JSPR | SELL | 2023-01-25 | 2023-01-26 | $1.89 | $142K | +5.0% | +6.1% | -33.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.